Pyrls on Instagram: Brexpiprazole's (REXULTI) new indication makes it the first FDA-approved option for agitation associated with dementia due to Alzheimer's disease ✨ Learn more about brexpiprazole in your Pyrls app or

292 likes, 1 comments - pyrls no May 14, 2023: "Brexpiprazole's (REXULTI) new indication makes it the first FDA-approved option for agitation ass"

Efficacy, Safety and Tolerability of Brexpiprazole for the Treatment of Agitation in Alzheimer's Dementia: A 12‐Week, Randomized, Double‐Blind, Placebo‐Controlled Trial - Grossberg - 2022 - Alzheimer's & Dementia - Wiley Online Library

FDA Approves First Treatment for Alzheimer's Agitation

REXULTI® (brexpiprazole) agitation that may happen with dementia due to Alzheimer's disease

Not Everyone Agreed With FDA Approval of Antipsychotic Rexulti for Agitation - Mad In America

Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation

Not Everyone Agreed With FDA Approval of Antipsychotic Rexulti for Agitation - Mad In America

Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation

First FDA Approved Medication for Agitation Associated with Alzheimer's Dementia – Psychiatry Education Forum

Not Everyone Agreed With FDA Approval of Antipsychotic Rexulti for Agitation - Mad In America

Not Everyone Agreed With FDA Approval of Antipsychotic Rexulti for Agitation - Mad In America

FDA Approves First Drug to Treat Agitation Symptoms Associated with Dementia due to Alzheimer's Disease - US FDA

Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation

FDA Approves First Drug to Treat Dementia-Associated Agitation in AD Patients